FDA pulls Avastin approval

WASHINGTON – The Food and Drug Administration has revoked its approval of the drug Avastin for breast cancer treatment, saying the drug has not been shown to be safe and effective for that use. The drug will retain its approval for the treatment of certain types of colon, lung, kidney and brain cancer. “This was ...